<?xml version="1.0" encoding="UTF-8"?>
<bio id="d35e47">
 <p>
  <graphic xlink:href="jpd-7-jpd179009-g001.gif" position="float" orientation="portrait" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <bold>Dr. Singleton</bold> is an NIH Distinguished Investigator within the National Institute on Aging at NIH. He identified alpha-synuclein multiplication mutations and 
  <italic>LRRK2</italic> mutations in Parkinson’s disease and has been a leader in the identification of risk loci for Parkinson’s disease. His laboratory has identified the genetic cause of more than a dozen forms of neurological disease and has identified hundreds of risk loci for various diseases and traits. He has been awarded the Jay van Andel Award for Outstanding Achievement in Parkinson’s Disease Research, the Annemarie Opprecht Foundation Award for Parkinson’s Disease Research, the NIH Director’s Award, and the American Academy of Neurology Movement Disorders Research Award. He has authored more than 500 publications.
 </p>
</bio>
